Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Robert Olivares"'
Autor:
Thomas Bovagnet, Hélène Verdoux, Josep Maria Haro, H Karcher, Javier Jimenez, Robert Olivares, Helene Chevrou-Severac, Lucien Abenhaim, Clementine Nordon, Mark Belger
Publikováno v:
Schizophrenia Research
Schizophrenia Research, Elsevier, 2018, 193, pp.146-153. ⟨10.1016/j.schres.2017.07.031⟩
Schizophrenia Research, Elsevier, 2018, 193, pp.146-153. ⟨10.1016/j.schres.2017.07.031⟩
Objectives To explore the impact upon estimation of drug effect as a result of applying exclusion criteria in randomized-controlled trials (RCT) measuring the efficacy of antipsychotics (AP) in schizophrenia. Methods Three characteristics which may a
Autor:
Rachel L. Police, Peter C. Trask, Jianmin Wang, Robert Olivares, Shahnaz Khan, Adeline Abbe, Ann Colosia, Annete Njue, Beth Sherrill, Rodrigo Ruiz-Soto, James A. Kaye, Mehdi Hamadani
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:199-207
This systematic literature review with meta-analysis was conducted on the clinical efficacy and safety of interventions used in the treatment of chronic lymphocytic leukemia (CLL). We systematically searched databases (PubMed, Cochrane Library, and E
Publikováno v:
European Journal of Haematology. 92:289-297
Background Primary myelofibrosis (PMF), essential thrombocythemia (ET), and polycythemia vera (PV) are BCR ABL-negative myeloproliferative neoplasms (MPN). Published epidemiology data are scarce, and multiple sources are needed to assess the disease
Autor:
Rachel L Police, Peter C Trask, Jianmin Wang, Robert Olivares, Shahnaz khan, Adeline Abbe, Ann Colosia, Annete Njue, Beth Sherril, Rodrigo Ruiz-Soto, James A Kaye, Mehdi Hamadani
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 22(5)
This systematic literature review evaluated the clinical efficacy and safety of interventions used in relapsed/refractory follicular lymphoma. Primary efficacy outcomes were objective response rate, progression-free survival and overall survival. Saf
Publikováno v:
Clinical Pharmacology & Therapeutics. 68:677-687
Background Pharmacokinetic and pharmacodynamic analyses conducted during the development of docetaxel showed that patients with non–small-cell lung cancer with high baseline α1-acid glycoprotein levels had shorter time to progression and time to d
Autor:
Maciej Krzakowski, Anna Pluzanska, Ulf Aasebø, Kazimierz Roszkowski, Annamaria Parisi, Alexander Peter Smith, Jocelyne Berille, Eugeni Saigi, Ngoc Pham Tran, Robert Olivares
Publikováno v:
Lung Cancer. 27:145-157
This was an open-label randomized Phase III study of 207 patients with either unresectable or metastatic non-small cell lung cancer (NSCLC) who were treated with docetaxel plus best supportive care (BSC) or best supportive care alone. Patients in the
Autor:
Pierre-Marie Girard, Roland Landman, Claude Gaudebout, Robert Olivares, Adrien Gerard Saimot, Patrick Jelazko, Christiane Gaudebout, Agnes Certain, Francois Boue, Elisabeth Bouvet, Thanh Lecompte, Pierre Jean-Coulaud
Publikováno v:
New England Journal of Medicine. 328:1514-1520
Background Pneumocystis carinii pneumonia and toxoplasmic encephalitis are frequent life-threatening opportunistic infections in patients with human immunodeficiency virus (HIV) infection. Primary prophylaxis against P. carinii pneumonia is now commo
Autor:
Annete Njue, Ann Colosia, Peter C. Trask, Robert Olivares, Shahnaz Khan, Adeline Abbe, Rachel Police, Jianmin Wang, Rodrigo Ruiz-Soto, James A. Kaye, Farrukh Awan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:1-12.e7
A systematic literature review was performed to collect and review information on the clinical efficacy and safety of treatments for relapsed/refractory (R/R) mantle cell lymphoma (MCL), with a meta-analysis, if possible. PubMed, Embase, and the Coch
Autor:
Nathalie Syz, Freddi Lewin, David N. Dalley, Madhu Mazumdar, Jean-Pierre Pignon, Adriano Paccagnella, Laurence Le Lann, Samuel G. Taylor, Christian Domenge, Marshall R. Posner, Jean Bourhis, Ariane Dunant, Antoine Yver, Robert Olivares
Publikováno v:
Anti-cancer drugs. 15(4)
When induction chemotherapy is used in locally advanced squamous cell cancer of the head and neck (SCCHN), patients often receive cisplatin-5-fluorouracil (PF) followed by radical loco-regional therapy. Phase II studies of docetaxel-cisplatin-5-fluor
Autor:
René, Bruno, Robert, Olivares, Jocelyne, Berille, Philip, Chaikin, Nicole, Vivier, Luz, Hammershaimb, Gerald R, Rhodes, James R, Rigas
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(3)
To identify predictors of treatment outcome and survival in patients with non-small cell lung cancer (NSCLC) treated with docetaxel.The data were collected from 180 NSCLC patients enrolled in six docetaxel Phase II studies at a dose of 100 mg/m(2). C